COMMUNIQUÉS West-GlobeNewswire

Zecotek Opens LFS Crystal Production Facility in Shanghai, China
03/07/2018
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Zecotek Photonics Inc. (“ Zecotek ” or the “ Company ”) (TSX-V:ZMS) (Frankfurt:W1I) (OTCPK:ZMSPF), a developer of leading-edge photonics technologies for [...]
Auris Medical Announces Publication Confirming Dose-Dependent Effects of Betahistine and Relationship to Bioavailability in Cat Model of Acute Vertigo
03/07/2018
Zug, Switzerland, July 3, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Elite Pharmaceuticals Receives FDA Approval for Generic Percocet® Tablets
03/07/2018
NORTHVALE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Auxly Provides Development Update on the FV Pharma Joint Venture
03/07/2018
VANCOUVER, British Columbia, July 03, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to provide the following construction development update on the joint [...]
Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
03/07/2018
ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints measuring Safety, and Cognitive and Functional Efficacy (ADAS [...]
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer
03/07/2018
iTeos Therapeutics Appoints Scott Chappel as Chief Scientific Officer Gosselies, Belgium – July 3, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced the [...]
Loop Industries Reports First Quarter of Fiscal 2019 Consolidated Results
03/07/2018
Announced activation of breakthrough Generation II technology Announced world’s first integrated waste to Loop™ PET resin manufacturing technology Company used $2.2 million for the quarter of cash in operating [...]
Milestone Scientific CompuFlo® Epidural System Selected to Objectively Measure the Integrity of a High Fidelity Epidural Simulator in Real Time; Research Article Published in Prominent Scientific Peer Reviewed Journal
03/07/2018
CompuFlo® Epidural System becoming accepted as best-in-class for measuring tissue density and needle location in real time LIVINGSTON, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE:MLSS), a [...]
The Ensign Group Acquires Idaho Skilled Nursing Facility
03/07/2018
MISSION VIEJO, Calif., July 03, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care and [...]
Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
03/07/2018
THOROFARE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces agreements with six [...]
Six zones de l’expansion de 250 000 pieds carrés des serres de HEXO sont maintenant entièrement autorisées et opérationnelles
03/07/2018
GATINEAU, Québec, 03 juill. 2018 (GLOBE NEWSWIRE) -- La Société Hydropothecary (TSX:HEXO) (« HEXO » ou « la Société ») est heureuse d'annoncer que six des dix zones de son expansion de 250 000 pieds carrés sont [...]
Six Zones of HEXO’s 250,000 sq. ft. Greenhouse Expansion Now Fully Licensed and Operational
03/07/2018
GATINEAU, Quebec, July 03, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that six of ten zones in its 250,000 sq. ft. greenhouse expansion are now [...]
Virbac : Declaration of the number of shares and voting rights as of June 2018, 30.
03/07/2018
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote au 30 Juin 2018
03/07/2018
DECLARATION D'ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d'actions composant le capital (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) [...]
Transactions in relation to share buyback program
03/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ASLAN Pharmaceuticals Submits Clinical Trial Authorisation Application for First in Man Studies for ASLAN004
03/07/2018
SINGAPORE, July 03, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (ASLAN, 6497.TT) (NASDAQ:ASLN), a clinical-stage biopharmaceutical company based in Asia developing novel therapeutics for global markets, today [...]
FIT Biotech Oy: FIT Biotech webcasts the company half-year financial report on September 6th 2018, at 10.00 AM.
03/07/2018
FIT Biotech Oy Press Release July 3 rd 2018, 10.00 EET FIT Biotech webcasts the company half-year financial report on September 6 th 2018, at 10.00 AM. FIT Biotech's half-year financial report will be webcasted on [...]
Shire plc : Rule 2.9 Announcement
03/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 July 2018 Shire [...]
Motif Bio Announces Resignation of Robert Bertoldi from Board of Directors
03/07/2018
NEW YORK, July 03, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Robert Bertoldi has [...]

Pages